Molecular Diagnostics
New Study to Help Identify Accurate microRNA Biomarkers for Early Detection and Treatment of Diabetes
Over the past two decades, researchers have conducted studies with animal or cell-based models which have suggested that specific small RNA molecules, called microRNAs, involved in controlling which genes are turned on and off in cells could help pancreatic islets develop and function normally. However, the specific role of these microRNAs in human pancreatic islets was poorly characterized. Now, a new large-scale genetic analysis has identified a set of microRNAs in pancreatic islets that are strongly associated with type 2 diabetes. More...14 Feb 2023
D-Dimer Blood Test Detects Prosthetic Joint Infections as Accurately as Standard Tests
Plasma D-dimer, a test commonly used for certain blood clot-related disorders, is a potentially useful marker of infection and has been validated for use in the diagnosis of periprosthetic joint infection (PJI). However, some studies have raised concerns over the diagnostic performance of D-dimer testing for PJI, and its true accuracy is still unknown. Now, a new study suggests that the measurement of plasma D-dimer levels can provide useful information when making the difficult diagnosis of PJI. More...13 Feb 2023
New Diagnostic Test 1,000 Times More Sensitive than Conventional Tests
In their effort to overcome the limitations of point-of-care diagnostic tests, researchers have now developed ultrabright fluorescent nanolabels called plasmonic-fluors, which can be quickly integrated into the lateral flow assay (LFA), a common testing platform. Plasmon-enhanced LFAs (p-LFAs) improve inexpensive, readily available rapid tests to the levels of sensitivity required by physicians for confidence in test results without the need for lab-based confirmation. More...13 Feb 2023
Unique Biomarker Could Lead to Diagnostic Tests for Detection of Early-Stage Alzheimer’s
Researchers have identified a new protein in the cerebrospinal fluid that can reliably detect endothelial injury in patients with Alzheimer’s disease. Using this biomarker, they found that endothelial injury is a key contributor to cognitive impairment during the earliest pre-symptomatic stages of the disease as well. More...10 Feb 2023
Voice-Activated Sample Pre-Treatment Device Enables Hands-Free, Safer DNA Handling
Scientists using samples containing pathogens work with the smallest amounts possible in order to avoid accidental infection. Now, the same technology used by smart voice assistants could also make the laboratory a safer place for scientists and technicians handling infectious samples. More...10 Feb 2023
World’s First AI-Powered Diagnostic Test Accurately Identifies Respiratory Viruses in Five Minutes
A world-first diagnostic test powered by AI that can identify known respiratory viruses within five minutes from just one nasal or throat swab could replace current testing methods which are limited to testing for just one infection or are either lab-based and time-consuming or fast and less accurate. More...09 Feb 2023
New Blood Test Detects Prostate Cancer With 94% Accuracy
Prostate cancer is the most common cancer in men, creating the need for a blood test that can detect it with greater accuracy. Now, new research shows that the (Prostate Screening EpiSwitch) ‘PSE’ blood test is 94% accurate and much superior than the currently used prostate-specific antigen (PSA) blood test. More...09 Feb 2023
Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Vitamin B12 Test
CHORUS CLIA VIT B12
New
Anti-Secukinumab ELISA
LISA-TRACKER anti-Secukinumab
In Other News
World’s First Comprehensive Risk Test for Breast & Ovarian Cancer Launched
New Assay Determines if Bladder Cancer Patients Need Radical Surgery
Urine Prostate Cancer Screening Test Offers Best-In-Class Accuracy and Stratified Risk Assessment
Nanotechnology-Based Blood Test Could Revolutionize Prostate Cancer Diagnosis
New Device Detects Brain Tumors Using Urine
New Blood Test Could Ensure Timely Life-Saving Treatment of Heart Attack Victims
Real-Time PCR System Advances Large Reaction Volume IVD Assay Development and Diagnostic Testing
Focused-Ultrasound-Mediated Liquid Biopsy to Facilitate Diagnosis of Neurodegenerative Disorders
Blood Test Predicts Alzheimer's Risk 3.5 Years Before Clinical Diagnosis
Novel Biomarker-Based Tests to Predict Response to Drugs for Treatment of Chronic Kidney Disease
Newly Identified Protein Biomarkers in Blood Predict Sudden Cardiac Arrest Before it Strikes
Blood Test Identifies Osteoarthritis Progression More Accurately than Current Methods
New DNA Biosensor Could Make High-Quality Clinical Diagnostics More Accessible
New Technique Enables Measurement of Thousands of Molecules from Single Blood Drop
Non-Invasive Blood Test Helps Select Treatment for Advanced Gastrointestinal Stromal Tumors
Non-Invasive Melanoma Test Ushers in New Era in Skin Cancer Detection
World’s First Molecular, Cell-Based Test Offers Non-Surgical Method for Diagnosis and Staging of Endometriosis
Rapid POC Diagnostic Assay Could Detect and Measure Fentanyl Neutralizing Antibodies
Molecular Diagnostic Platform for Automated Sample Processing to Help Labs Achieve New Flexibility Level
Early Alzheimer’s Detection Sensor Could Also Diagnose Other Diseases at POC
First-Of-A-Kind Pan-Cancer Blood Test Could Predict Immunotherapy Efficacy and Toxicity
World’s First Test Detects Diabetics at Risk of Kidney Disease before Symptoms Appear
ELISAs Reliably Detect Anti-CCHFV Antibodies in Acute Infections
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.